A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes
Clinical trial NCT00000645 · COMPLETED
Trial details
- NCT number
- NCT00000645
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.